Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 100 of 2228 entries
View as:

A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT06647810 Org: User:
Start: 11/13/24 End: 01/07/25 Due: 01/07/26

PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin

Phase: N/A Priority: Normal
NCT ID: NCT01227629 Org: User:
Start: 09/30/03 End: - Due: -

Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals

Phase: N/A Priority: Normal
NCT ID: NCT00034866 Org: User:
Start: 04/30/02 End: 10/31/02 Due: 10/31/03

A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04137289 Org: User:
Start: 03/11/20 End: 11/27/23 Due: 11/27/24

A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)

Phase: N/A Priority: Normal
NCT ID: NCT02200653 Org: User:
Start: 05/31/00 End: - Due: -

Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01011868 Org: User:
Start: 11/30/09 End: - Due: -

Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01340209 Org: User:
Start: 04/30/11 End: 04/30/13 Due: 04/30/14

A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS)

Phase: N/A Priority: Normal
NCT ID: NCT00144183 Org: User:
Start: 01/31/03 End: 01/31/07 Due: 01/31/08

Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS for HandiHaler® in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02216461 Org: User:
Start: 01/31/06 End: - Due: -

Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions

Phase: N/A Priority: Normal
NCT ID: NCT01764945 Org: User:
Start: 01/31/13 End: 03/31/13 Due: 03/31/14

A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.

Phase: N/A Priority: Normal
NCT ID: NCT03238963 Org: User:
Start: 09/19/17 End: 05/14/20 Due: 05/14/21

Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)

Phase: N/A Priority: Normal
NCT ID: NCT00321854 Org: User:
Start: 05/31/06 End: - Due: -

Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00553267 Org: User:
Start: 11/30/07 End: - Due: -

A Study in Healthy Men to Find the Best Formulation for Once Daily Intake of Nintedanib

Phase: N/A Priority: Normal
NCT ID: NCT05262751 Org: User:
Start: 03/28/22 End: 11/30/22 Due: 11/30/23

Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM

Phase: N/A Priority: Normal
NCT ID: NCT00274612 Org: User:
Start: 10/31/02 End: 11/30/03 Due: 11/30/04

A Study in Healthy People to Test How Well Different Doses of BI 3000202 Are Tolerated and How They Affect the Way the Body Handles Midazolam

Phase: N/A Priority: Normal
NCT ID: NCT06327256 Org: User:
Start: 04/09/24 End: 09/27/24 Due: 09/27/25

Pharmacokinetic Interaction Between Tipranavir and BILR 355 BS Plus Ritonavir in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02257021 Org: User:
Start: 02/28/05 End: - Due: -

Multiple Oral Doses of BI 207127 NA in Treatment naïve and Treatment-experienced Hepatitis C Virus (HCV)-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT02176525 Org: User:
Start: 12/31/07 End: - Due: -

Medical Need of OAC Reversal

Phase: N/A Priority: Normal
NCT ID: NCT03254147 Org: User:
Start: 10/15/17 End: 11/10/17 Due: 11/10/18

Safety, Tolerability and Pharmacokinetics of Single Rising Doses of BIIB 722 CL and HPβCD in Young Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02224079 Org: User:
Start: 04/30/02 End: - Due: -

A Study to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body of Healthy Japanese Men

Phase: N/A Priority: Normal
NCT ID: NCT06494774 Org: User:
Start: 08/19/24 End: 11/13/24 Due: 11/13/25

Relative Oral Bioavailability of BI 44847 as Suspension Compared to Tablet and the Influence of Food Anf of BI 44847 as Solution Compared to Tablet in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02211937 Org: User:
Start: 01/31/07 End: - Due: -

Effect of Food on the Pharmacokinetics of Meloxicam in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02181309 Org: User:
Start: 01/31/02 End: - Due: -

Tiotropium In Exercise

Phase: N/A Priority: Normal
NCT ID: NCT00525512 Org: User:
Start: 08/31/07 End: - Due: -

Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of BI 201335 NA and Bioavailability in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02182323 Org: User:
Start: 09/30/06 End: - Due: -